As part of its sustainability strategy “Beyond: Taking action for a brighter world”, Dentsply Sirona has expanded its successful engagement for children with clefts by entering a landmark partnership to advance cleft care and bring health and opportunity to live a happier life to countless children.
Today, Dentsply Sirona, the world’s largest manufacturer of professional dental products and technologies, announced a three-way partnership with FDI World Dental Federation (FDI) and Smile Train, the world’s largest cleft-focused organization, to develop global standard protocols for digital cleft treatment that will increase access to digital treatments for patients with clefts and advance cleft care for the 1 in 700 babies born with cleft lip and/or palate around the globe.
The three partners will jointly work on integrating digital workflows and sustainable solutions into these new protocols as well as creating and providing the necessary clinical education infrastructure to oral health professionals around the world. The unique partnership also includes designing and setting up online courses and webinars to introduce dental professionals around the world to digital cleft care.
Prior to this new partnership, Dentsply Sirona pledged a five-million-dollar donation to Smile Train as part of a five-year commitment to help children around the world gain access to cleft treatment, offering them the chance to live full and healthy lives.
“At Dentsply Sirona, we live our sustainability strategy every day in numerous ways. One of the most rewarding aspects is working with Smile Train and FDI to be able to offer the best care possible to children with clefts,” says Jorge M. Gomez, Chief Financial Officer and Head of the Dentsply Sirona Sustainability Program. “Giving these children healthy smiles by utilizing the most advanced digital technologies is part of our larger sustainability goal to improve global oral health care and create millions of healthy smiles around the world. We are happy to contribute our knowledge and technologies for this important cause.”
“We are proud to be working with Dentsply Sirona and Smile Train to increase the global access to the best possible cleft care,” says Prof. Ihsane Ben Yahya, President, FDI World Dental Federation. “Cleft surgeries and cleft care benefit hugely from digitization and together with our partners we work fervently on providing oral health professionals, especially in limited-resource settings and remote regions, with the infrastructure and training necessary to correctly use these digital technologies.”
“Children with clefts are more susceptible to poor oral health which can greatly impact their speech, ability to eat, and their overall well-being,” says Susannah Schaefer, President & Chief Executive Officer, Smile Train. “We are delighted that our new partnership with Dentsply Sirona and FDI ensures that Smile Train centers around the world will have access to digital treatment protocols that integrate the latest, newest technologies to provide best-in-class digital oral healthcare.”
ABOUT DENTSPLY SIRONA
Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solution offering, including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona’s headquarters are located in Charlotte, North Carolina. The company’s shares are listed in the United States on NASDAQ under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
This information and any attachment thereto contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as “may,” “could,” “estimate,” “will,” “believe,” “anticipate,” “think,” “intend,” “expect,” “project,” “plan,” “target,” “forecast”, and similar words and expressions. However, these words are not the exclusive means of identifying such statements. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the Company’s products, the possibility of changing economic, market and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the Company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.
Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.